Mingjing Chen
5 Papers
Mingjing Chen is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 5 publications.
Chat about Author
Papers
Epidemiology and prediction model of patients with carcinosarcoma in the United States
Mingjing Chen,Xiandong He,Qiaozhu Yang,Jia Zhang,J. Peng,Danni Wang,Kexin Tong,Wen-Hui Huang +7 more
TL;DR: In this paper , a nomogram was established to predict 1-, 3-, and 5-year survival, and the C-indexes were 0.732 and 0.748 for the training and testing sets, respectively.
2
Real-World Efficacy of Bevacizumab in Patients With Recurrent Epithelial Ovarian Cancer
Jonathon Hung,Shih-Tien Hsu,Lou Sun,Sheau-Feng Hwang,Chih Ku Liu,Y. Shih,Mingjing Chen,Jun-Sing Wang,Chien-Hsing Lu +8 more
TL;DR: The findings provided crucial insights into the efficacy of bevacizumab for the treatment of recurrent EOC in the real-world setting in a retrospective cohort study using data from an Asian population.
Improved Progression-Free Survival Associated with Tumor-Infiltrating Lymphocytes in High-Grade Endometrial Cancer
Chun-Ting Fan,Shih-Tien Hsu,Lou Sun,Sheau-Feng Hwang,Chih Ku Liu,Y. Shih,Mingjing Chen,Hsin-Ni Li,Jun-Sing Wang,Mei-Chin Wen,Chien-Hsing Lu +10 more
TL;DR: Tumor-infiltrating lymphocytes (TILs) have emerged as a prognostic marker in endometrial cancer (EC) as discussed by the authors , but the role of TILs in EC with distinct histology grades and molecular types (such as mismatch repair [MMR] deficiency) has not yet been made clear.
The histone deacetylase SIRT6 promotes glycolysis through the HIF-1α/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer
Qiai You,Jianmin Wang,Yongxin Yu,Feng Li,Lingxin Meng,Mingjing Chen,Qiaozhu Yang,Zihan Xu,Jianguo Sun,Wenlei Zhuo,Zhengtang Chen +10 more
TL;DR: In this paper , the authors explored strategies to overcome erlotinib resistance from the perspective of energy metabolism and found that high expression of SIRT6 is associated with poor prognosis of lung adenocarcinoma, especially in EGFR-mutated NSCLC patients.
Association of Radioiodine for Differentiated Thyroid Cancer and Second Breast Cancer in Female Adolescent and Young Adult
Xianlan Zhao,Mingjing Chen,Xiaojing Qi,Haizhen Zhu,Guangrong Yang,Yi Guo,Qiong Dong,Qiaozhu Yang +7 more
TL;DR: RAI treatment increased the risk of SBC in female AYA DTC patients and the survival after SBC was inferior to those with matched only primary breast cancer.